Differential effects of donor lymphocyte infusion upon treatment response and GVHD according to relapse level and donor sources in patients with myelodysplastic syndrome

INTRODUCTION: Donor lymphocyte infusion (DLI) is one of the effective options for post-transplant disease control of myelodysplastic syndrome (MDS). Its success or failure depends on the induction of antitumor immune reactions, durability of clinical responses, and severity of unwanted toxicities ma...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Silvia, Kim, Tong Yoon, Lee, Jong Hyuk, Lee, Joon yeop, Min, Gi June, Park, Sung Soo, Yahng, Seung-Ah, Shin, Seung-Hwan, Yoon, Jae-Ho, Lee, Sung-Eun, Cho, Byung Sik, Eom, Ki-Seong, Lee, Seok, Kim, Hee-Je, Min, Chang-Ki, Lee, Jong Wook, Kim, Yoo-Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8474341/
https://www.ncbi.nlm.nih.gov/pubmed/34589195
http://dx.doi.org/10.1177/20406207211043748

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8474341/
https://www.ncbi.nlm.nih.gov/pubmed/34589195
http://dx.doi.org/10.1177/20406207211043748

Ejemplares similares